Literature DB >> 17360935

How I treat patients with diffuse large B-cell lymphoma.

James O Armitage1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17360935     DOI： 10.1182/blood-2007-01-041871

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  41 in total

1.  My treatment approach to patients with diffuse large B-cell lymphoma.

Authors:  James O Armitage
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Cross-platform assessment of genomic imbalance confirms the clinical relevance of genomic complexity and reveals loci with potential pathogenic roles in diffuse large B-cell lymphoma.

Authors:  Lizalynn M Dias; Venkata Thodima; Julia Friedman; Charles Ma; Asha Guttapalli; Geetu Mendiratta; Imran N Siddiqi; Sergei Syrbu; R S K Chaganti; Jane Houldsworth
Journal:  Leuk Lymphoma       Date:  2015-11-16

3.  Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.

Authors:  Ana Borovecki; Petra Korać; Marin Nola; Davor Ivanković; Branimir Jaksić; Mara Dominis
Journal:  Croat Med J       Date:  2008-10       Impact factor: 1.351

4.  Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphoma.

Authors:  Changhoon Yoo; Dok Hyun Yoon; Jeong Eun Kim; Jungmin Jo; Seong Joon Park; Shin-Kyo Yoon; Yongchel Ahn; Shin Kim; Jooryung Huh; Dae Ho Lee; Cheolwon Suh
Journal:  Int J Hematol       Date:  2013-01-29       Impact factor: 2.490

5.  Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States.

Authors:  Chadi Nabhan; Michelle Byrtek; Ashish Rai; Keith Dawson; Xiaolei Zhou; Brian K Link; Jonathan W Friedberg; Andrew D Zelenetz; Matthew J Maurer; James R Cerhan; Christopher R Flowers
Journal:  Br J Haematol       Date:  2015-04-07       Impact factor: 6.998

6.  Primary Urinary Tract Lymphoma: Rare but Aggressive.

Authors:  Konstantinos Lontos; Anastasia Tsagianni; Pavlos Msaouel; Leonard Joseph Appleman; Dimitrios Nasioudis
Journal:  Anticancer Res       Date:  2017-12       Impact factor: 2.480

Review 7.  Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma.

Authors:  Vijaya Raj Bhatt
Journal:  Curr Hematol Malig Rep       Date:  2016-06       Impact factor: 3.952

8.  Unilateral lower extremity swelling as a rare presentation of non-Hodgkin's lymphoma.

Authors:  Islam Y Elgendy; Margaret C Lo
Journal:  BMJ Case Rep       Date:  2014-01-15

9.  Rituximab-including combined modality treatment for primary thyroid lymphoma: an effective regimen for elderly patients.

Authors:  Natsuko Watanabe; Hiroto Narimatsu; Jaeduk Yoshimura Noh; Yo Kunii; Koji Mukasa; Masako Matsumoto; Miho Suzuki; Kenichi Sekiya; Hidemi Ohye; Ai Yoshihara; Kenji Iwaku; Sakiko Kobayashi; Sachiko Kobayashi; Kaori Kameyama; Kazuhiko Kobayashi; Yoshitaka Nishikawa; Masahiro Kami; Kiminori Sugino; Koichi Ito
Journal:  Thyroid       Date:  2014-05-15       Impact factor: 6.568

Review 10.  A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma.

Authors:  Maurilio Ponzoni; Silvia Govi; Giada Licata; Silvia Mappa; Antonio Giordano Resti; Letterio S Politi; Lorenzo Spagnuolo; Eliana Di Cairano; Claudio Doglioni; Andrés J M Ferreri
Journal:  Oncologist       Date:  2013-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.